Skip to main navigation Skip to search Skip to main content

Synergistic anticancer effects of ruxolitinib and calcitriol in estrogen receptor-positive, human epidermal growth factor receptor 2-positive breast cancer cells

  • The Catholic University of Korea, St. Vincent's Hospital

Research output: Contribution to journal › Article › peer-review

23 Scopus citations

Fingerprint

Dive into the research topics of 'Synergistic anticancer effects of ruxolitinib and calcitriol in estrogen receptor-positive, human epidermal growth factor receptor 2-positive breast cancer cells'. Together they form a unique fingerprint.
Sort by

Biochemistry, Genetics and Molecular Biology

Pharmacology, Toxicology and Pharmaceutical Science